Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study

Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study

Introduction Several reports have noted that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induced lymphopenia in coronavirus disease 2019 (COVID-19) patients. However, the clinical significance of lymphopenia remains unclear. The objective of this study was to analyze the association...

Full description

Bibliographic Details
Main Authors: Jun Fei, Lin Fu, Ying Li, Hui-Xian Xiang, Ying Xiang, Meng-Die Li, Fang-Fang Liu, De-Xiang Xu, Hui Zhao
Format: Article
Language:English
Published: Termedia Publishing House 2020-09-01
Series:Archives of Medical Science
Subjects:
coronavirus disease 2019
severe acute respiratory syndrome coronavirus-2
multiple organ injuries
severity
death risk
Online Access:https://www.archivesofmedicalscience.com/Reduction-of-lymphocyte-count-at-early-stage-elevates-severity-and-death-risk-of,126224,0,2.html

Internet

https://www.archivesofmedicalscience.com/Reduction-of-lymphocyte-count-at-early-stage-elevates-severity-and-death-risk-of,126224,0,2.html

Similar Items